
Global Live Attenuated Vaccines Market Research Report 2025(Status and Outlook)
Description
Report Overview
Live attenuated vaccines are a type of immunization that uses a weakened but live form of the pathogen (virus or bacteria) to stimulate a strong and long-lasting immune response without causing the actual disease. These vaccines closely mimic natural infections, leading to robust cellular and antibody-mediated immunity, often requiring fewer doses compared to inactivated vaccines. Examples include vaccines for measles, mumps, rubella (MMR), yellow fever, and varicella (chickenpox). While highly effective, they may pose risks for immunocompromised individuals, as the weakened pathogen could potentially cause disease in those with weakened immune systems. The development and production of live attenuated vaccines involve complex processes, including pathogen attenuation through serial passage or genetic modification, ensuring safety while maintaining immunogenicity. Their stability and potential for single-dose administration make them valuable in global immunization programs, particularly in resource-limited settings.
The global Live Attenuated Vaccines market size was estimated at USD 31070.08 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.16% during the forecast period.
This report provides a deep insight into the global Live Attenuated Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Vaccines market in any manner.
Global Live Attenuated Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson and Johnson
CSL
Sanofi
Serum Institute Of India
Market Segmentation (by Type)
Bacterial
Viral
Market Segmentation (by Application)
Hospitals
Clinics
Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Attenuated Vaccines Market
Overview of the regional outlook of the Live Attenuated Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Attenuated Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Live attenuated vaccines are a type of immunization that uses a weakened but live form of the pathogen (virus or bacteria) to stimulate a strong and long-lasting immune response without causing the actual disease. These vaccines closely mimic natural infections, leading to robust cellular and antibody-mediated immunity, often requiring fewer doses compared to inactivated vaccines. Examples include vaccines for measles, mumps, rubella (MMR), yellow fever, and varicella (chickenpox). While highly effective, they may pose risks for immunocompromised individuals, as the weakened pathogen could potentially cause disease in those with weakened immune systems. The development and production of live attenuated vaccines involve complex processes, including pathogen attenuation through serial passage or genetic modification, ensuring safety while maintaining immunogenicity. Their stability and potential for single-dose administration make them valuable in global immunization programs, particularly in resource-limited settings.
The global Live Attenuated Vaccines market size was estimated at USD 31070.08 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.16% during the forecast period.
This report provides a deep insight into the global Live Attenuated Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Vaccines market in any manner.
Global Live Attenuated Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson and Johnson
CSL
Sanofi
Serum Institute Of India
Market Segmentation (by Type)
Bacterial
Viral
Market Segmentation (by Application)
Hospitals
Clinics
Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Attenuated Vaccines Market
Overview of the regional outlook of the Live Attenuated Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Attenuated Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
136 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Live Attenuated Vaccines
- 1.2 Key Market Segments
- 1.2.1 Live Attenuated Vaccines Segment By Type
- 1.2.2 Live Attenuated Vaccines Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Live Attenuated Vaccines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Live Attenuated Vaccines Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Live Attenuated Vaccines Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Live Attenuated Vaccines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Live Attenuated Vaccines Product Life Cycle
- 3.3 Global Live Attenuated Vaccines Sales By Manufacturers (2020-2025)
- 3.4 Global Live Attenuated Vaccines Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Live Attenuated Vaccines Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Live Attenuated Vaccines Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Live Attenuated Vaccines Market Competitive Situation And Trends
- 3.8.1 Live Attenuated Vaccines Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Live Attenuated Vaccines Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Live Attenuated Vaccines Industry Chain Analysis
- 4.1 Live Attenuated Vaccines Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Live Attenuated Vaccines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Live Attenuated Vaccines Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Live Attenuated Vaccines Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Live Attenuated Vaccines Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Live Attenuated Vaccines Sales Market Share By Type (2020-2025)
- 6.3 Global Live Attenuated Vaccines Market Size Market Share By Type (2020-2025)
- 6.4 Global Live Attenuated Vaccines Price By Type (2020-2025)
- 7 Live Attenuated Vaccines Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Live Attenuated Vaccines Market Sales By Application (2020-2025)
- 7.3 Global Live Attenuated Vaccines Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Live Attenuated Vaccines Sales Growth Rate By Application (2020-2025)
- 8 Live Attenuated Vaccines Market Sales By Region
- 8.1 Global Live Attenuated Vaccines Sales By Region
- 8.1.1 Global Live Attenuated Vaccines Sales By Region
- 8.1.2 Global Live Attenuated Vaccines Sales Market Share By Region
- 8.2 Global Live Attenuated Vaccines Market Size By Region
- 8.2.1 Global Live Attenuated Vaccines Market Size By Region
- 8.2.2 Global Live Attenuated Vaccines Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Live Attenuated Vaccines Sales By Country
- 8.3.2 North America Live Attenuated Vaccines Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Live Attenuated Vaccines Sales By Country
- 8.4.2 Europe Live Attenuated Vaccines Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Live Attenuated Vaccines Sales By Region
- 8.5.2 Asia Pacific Live Attenuated Vaccines Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Live Attenuated Vaccines Sales By Country
- 8.6.2 South America Live Attenuated Vaccines Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Live Attenuated Vaccines Sales By Region
- 8.7.2 Middle East And Africa Live Attenuated Vaccines Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Live Attenuated Vaccines Market Production By Region
- 9.1 Global Production Of Live Attenuated Vaccines By Region(2020-2025)
- 9.2 Global Live Attenuated Vaccines Revenue Market Share By Region (2020-2025)
- 9.3 Global Live Attenuated Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Live Attenuated Vaccines Production
- 9.4.1 North America Live Attenuated Vaccines Production Growth Rate (2020-2025)
- 9.4.2 North America Live Attenuated Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Live Attenuated Vaccines Production
- 9.5.1 Europe Live Attenuated Vaccines Production Growth Rate (2020-2025)
- 9.5.2 Europe Live Attenuated Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Live Attenuated Vaccines Production (2020-2025)
- 9.6.1 Japan Live Attenuated Vaccines Production Growth Rate (2020-2025)
- 9.6.2 Japan Live Attenuated Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Live Attenuated Vaccines Production (2020-2025)
- 9.7.1 China Live Attenuated Vaccines Production Growth Rate (2020-2025)
- 9.7.2 China Live Attenuated Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Glaxosmithkline
- 10.1.1 Glaxosmithkline Basic Information
- 10.1.2 Glaxosmithkline Live Attenuated Vaccines Product Overview
- 10.1.3 Glaxosmithkline Live Attenuated Vaccines Product Market Performance
- 10.1.4 Glaxosmithkline Business Overview
- 10.1.5 Glaxosmithkline Swot Analysis
- 10.1.6 Glaxosmithkline Recent Developments
- 10.2 Merck
- 10.2.1 Merck Basic Information
- 10.2.2 Merck Live Attenuated Vaccines Product Overview
- 10.2.3 Merck Live Attenuated Vaccines Product Market Performance
- 10.2.4 Merck Business Overview
- 10.2.5 Merck Swot Analysis
- 10.2.6 Merck Recent Developments
- 10.3 Pfizer
- 10.3.1 Pfizer Basic Information
- 10.3.2 Pfizer Live Attenuated Vaccines Product Overview
- 10.3.3 Pfizer Live Attenuated Vaccines Product Market Performance
- 10.3.4 Pfizer Business Overview
- 10.3.5 Pfizer Swot Analysis
- 10.3.6 Pfizer Recent Developments
- 10.4 Astellas Pharma
- 10.4.1 Astellas Pharma Basic Information
- 10.4.2 Astellas Pharma Live Attenuated Vaccines Product Overview
- 10.4.3 Astellas Pharma Live Attenuated Vaccines Product Market Performance
- 10.4.4 Astellas Pharma Business Overview
- 10.4.5 Astellas Pharma Recent Developments
- 10.5 Johnson And Johnson
- 10.5.1 Johnson And Johnson Basic Information
- 10.5.2 Johnson And Johnson Live Attenuated Vaccines Product Overview
- 10.5.3 Johnson And Johnson Live Attenuated Vaccines Product Market Performance
- 10.5.4 Johnson And Johnson Business Overview
- 10.5.5 Johnson And Johnson Recent Developments
- 10.6 Csl
- 10.6.1 Csl Basic Information
- 10.6.2 Csl Live Attenuated Vaccines Product Overview
- 10.6.3 Csl Live Attenuated Vaccines Product Market Performance
- 10.6.4 Csl Business Overview
- 10.6.5 Csl Recent Developments
- 10.7 Sanofi
- 10.7.1 Sanofi Basic Information
- 10.7.2 Sanofi Live Attenuated Vaccines Product Overview
- 10.7.3 Sanofi Live Attenuated Vaccines Product Market Performance
- 10.7.4 Sanofi Business Overview
- 10.7.5 Sanofi Recent Developments
- 10.8 Serum Institute Of India
- 10.8.1 Serum Institute Of India Basic Information
- 10.8.2 Serum Institute Of India Live Attenuated Vaccines Product Overview
- 10.8.3 Serum Institute Of India Live Attenuated Vaccines Product Market Performance
- 10.8.4 Serum Institute Of India Business Overview
- 10.8.5 Serum Institute Of India Recent Developments
- 11 Live Attenuated Vaccines Market Forecast By Region
- 11.1 Global Live Attenuated Vaccines Market Size Forecast
- 11.2 Global Live Attenuated Vaccines Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Live Attenuated Vaccines Market Size Forecast By Country
- 11.2.3 Asia Pacific Live Attenuated Vaccines Market Size Forecast By Region
- 11.2.4 South America Live Attenuated Vaccines Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Live Attenuated Vaccines By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Live Attenuated Vaccines Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Live Attenuated Vaccines By Type (2026-2033)
- 12.1.2 Global Live Attenuated Vaccines Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Live Attenuated Vaccines By Type (2026-2033)
- 12.2 Global Live Attenuated Vaccines Market Forecast By Application (2026-2033)
- 12.2.1 Global Live Attenuated Vaccines Sales (K Mt) Forecast By Application
- 12.2.2 Global Live Attenuated Vaccines Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.